(Last updated : 2026-07-28 13:32:40)
  INAKAWA Tooru
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Assistant Professor
■ Published papers
1. Other  Increased risk of interstitial lung disease with enfortumab vedotin plus pembrolizumab compared with sequential enfortumab vedotin in metastatic urothelial carcinoma: A multicenter retrospective study in JAPAN. 2026/05 Link
2. Original article  Outcomes of enfortumab vedotin treatment in patients ineligible for the EV‐301 trial. 2025/09
3. Other  Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. 2025/05 Link
■ Academic conference presentation
1. Increased risk of interstitial lung disease with enfortumab vedotin plus pembrolizumab compared with sequential enfortumab vedotin in metastatic urothelial carcinoma: A multicenter retrospective study in JAPAN. (Poster notice,General) 2026/05/18
2. Real world data of enfortumab vedotin plus pembrolizumab for metastatic urothelial carcinoma: Multi-center retrospective study in Japan. (Speech,General) 2026/04/24
3. Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. (Poster notice,General) 2025/04/29
4. Surgical results of laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma at Saiseikai Kawaguchi General Hospital. (Poster notice,General) 2023/04/22
5. A Clinical review of 20 with hemodialysis patients renal cell carcinomas who underwent nephrectomy at Saiseikai Kawaguchi General Hospital. (Poster notice,General) 2023/04/21
Display all(6)